COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Metabolic syndrome components correlation with colorectal neoplasms: A systematic review and a meta-analysis
- Comparison of five solvents in the extraction of phenolic antioxidants from pomegranate (Punica granatum L.) peel
- Association of obesity with the lower limbs osteoarthritis in a community of women from El Jadida province in Morocco
- Statistical study of the relationship between hyperuricemia, dyslipidemia and type 2 diabetes in rural population of Tizi-Ouzou, Algeria
- In vitro, antioxidant activities of aqueous and methanol roselle (Hibiscus sabdariffa) calyces extracts from two localities in Cameroon
- Diet, weight status, and physical activity in cancer prevention
- Bioenrichment using Satureja montana L. essential oil for the prevention against photooxidation of flavored extra virgin olive oil during light display
- Cross‐sectional association between lifestyle behavior and cardiometabolic biomarkers in west Algerian postmenopausal women
- Effect of healthy lifestyle promotion on anthropometric variables, eating behavior and cardiometabolic risk factors in women with polycystic ovarian syndrome
- Update of the Nutrition Situation in Nigeria
You may also start an advanced similarity search for this article.

NAJFNR is licensed under